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Endovascular treatment of chronic total occlusions (CTO) of the 
infrainguinal artery is a reliable and safe alternative therapeutic 
option to surgery for the treatment of obstructive disease.
Thanks to growing experience and the use of drug-eluting tech-
nologies, the long-term results of de novo1 and recurrent occlu-
sions2 are satisfactory. Therefore, at present, the remaining limiting 
factor is gaining the true lumen distal to the occlusion (i.e., pro-
cedural success).
Today, the ability of each endovascular specialist to gain the 
distal lumen of an infrainguinal CTO is improving more and 
more3. At the same time, it is becoming more frequent than ever 
to have to face these extremely challenging occlusions in complex 
patients with difficult anatomic settings.
In the last decade, there has been a proliferation of strategies 
and devices designed to improve procedural success and outcomes 
in patients with infrainguinal CTO. Dedicated wires, support 
microcatheters, pedal access, intrastent punctures, re-entry devices 
and centre crossing devices have recently been developed4.
There are two possible procedural strategies to address an 
infrainguinal occlusion (Figure 1).
Subintimal navigation: a well-characterised, historical tech-
nique, which limits the choice of adjunctive devices and often 
requires the use of re-entry devices (i.e., angio-guided, IVUS-
guided, OCT-guided) to achieve the true distal lumen positioning 
of the guidewire.
Central lumen navigation: clinically preferred on account of the 
fact that it maximises therapeutic options allowing the use of all 
adjunctive devices. Often, dedicated devices (i.e., basket-like, cen-
tring balloons) designed to facilitate central lumen guidewire navi-
gation are needed.
The most challenging of the endovascular therapeutic proce-
dures remains the CTO located at the popliteal and infrapopliteal 
level. Not only do these procedures require significant time, radia-
tion and contrast use, but also they are associated with suboptimal 
procedural success and higher complication (i.e., arterial dissec-
tion and/or perforation, distal embolisation and bleeding) rates.
In this issue, Jalal et al5 report the results of a single-centre trial 
evaluating the safety and efficacy of two different devices for central
Article, see page 1063
lumen recanalisation of peripheral CTO lesions after an unsuccess-
ful attempt with a conventional technique. Despite a relatively long 
average lesion length (>15 cm), the procedural success was elevated 
and achieved with a relatively short crossing time (<6 minutes), low 
volume of contrast medium and short fluoroscopy time, and without 
paying the price of a higher procedural complication rate.
These favourable outcomes were achieved despite the fact that 
the vast majority of treated lesions were popliteal or infrapopliteal, 
as opposed to most other studies where the majority of treated 
CTO were superficial femoral artery lesions.
As operators, we should always remember that recanalisation 
of popliteal and infrapopliteal occlusions is associated with unsuc-
cessful results and various potential complications (arterial perfo-
ration, collateral branch occlusion), mainly related to the use of 
subintimal recanalisation. The devices tested in this study allow 
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obtaining a central lumen recanalisation and maximise therapeutic 
options, including the use of directional atherectomy to treat cal-
cific obstructions6.
There are some current economic and procedural concerns 
about the broad application of crossing devices in all popliteal and 
infrapopliteal lesions.
– It increases the cost of the procedure considerably.
– The prolonged procedural time, as a result of crossing attempts 
with different strategies (intraluminal, subintimal, centring 
devices) and the necessity of repeated angiograms, can restrict 
the application of these devices in elderly fragile patients or in 
patients with chronic kidney disease.
There is no current literature describing the value of using 
central lumen devices as a first-line attempt to recanalise infrap-
opliteal arteries. It would be desirable to have a study investigating 
whether this approach is able to reduce the overall procedural time, 
costs and contrast load. The use of dedicated (re-entry or central 
lumen) devices allows increasing procedural success, and more 
data on their role in facilitating complex procedures are needed.
One final comment should be made on our role as physicians 
involved in the research and cure of peripheral athero-occlusive 
disease. We should praise the efforts of industry and physicians 
in developing and validating new devices with the aim of facili-
tating our work as endovascular specialists, but we should never 
forget to continue our efforts in spreading awareness of athero-
occlusive peripheral artery disease.
Infrainguinal occlusions are more frequent in patients with 
a long history of untreated peripheral artery disease and, today, 
we need tools which will facilitate achieving a satisfactory clinical 
success rate. Our ambition should be to reach a point where we 
Figure 1. Strategies for endovascular recanalisation of peripheral artery atherothrombotic occlusion. A) Schematic representation of 
a peripheral artery atherothrombotic occlusion. The arterial artery is represented as composed of three layers (intima: red; media: pale 
yellow; adventitia: dark yellow). An atherothrombotic plaque (grey) is completely obstructing the arterial lumen. B) Central lumen 
navigation strategy. A dedicated guidewire is advanced and navigated into the true lumen of the atherothrombotic occlusion. C) Successful 
recanalisation of the atherothrombotic occlusion using a central lumen strategy. The wire tip is located in the true lumen, distal to the 
atherothrombotic occlusion. D) Unsuccessful recanalisation of the atherothrombotic occlusion using a central lumen strategy. The wire 
cannot be advanced into the central lumen, bends and deviates to the vessel wall. E) Successful recanalisation of the atherothrombotic 
occlusion using a central lumen strategy thanks to the use of a dedicated centring device able to support the wire navigation in the central 
lumen. F) Subintimal navigation strategy. A dedicated wire has been advanced and looped in the subintimal space of the atherothrombotic 
occlusion. G) Successful recanalisation of the atherothrombotic occlusion using a subintimal navigation strategy. The looped tip of the wire 
is advanced into the subintimal space distal to the occluded arterial segment and successfully re-entered into the true lumen, distal to the 
atherothrombotic occlusion. H) Unsuccessful recanalisation of the atherothrombotic occlusion after a subintimal navigation strategy. The 
looped tip of the wire is advanced into the subintimal space distal to the occluded arterial segment but re-entry in the true lumen distal to the 
atherothrombotic occlusion failed. I) Successful recanalisation of the atherothrombotic occlusion with a subintimal navigation strategy using 
a dedicated re-entry catheter. The dedicated catheter is advanced into the subintimal space distal to the atherothrombotic occlusion and 
allows the distal tip of the guidewire to re-enter into the true arterial lumen.
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Endovascular treatment of infrainguinal CTO
will approach these obstructions at a very early stage after symp-
tom onset, when they can be treated easily with high procedural 
success and low complication rates.
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